Reilly Financial Advisors’s ResMed RMD Stock Holding History

Reilly Financial Advisors’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-101	Closed	-$27K	–	1192
2021 Q3	$27K	Hold	101	–	–	﹤0.01%	478
2021 Q2	$25K	Hold	101	–	–	﹤0.01%	502
2021 Q1	$20K	Hold	101	–	–	﹤0.01%	542
2020 Q4	$21K	Buy	+101	New	+$20.1K	﹤0.01%	486
2016 Q3	–	Sell	-200	Closed	-$13K	–	877
2016 Q2	$13K	Buy	+200	New	+$11.8K	﹤0.01%	457
2015 Q1	–	Sell	-101	Closed	-$6K	–	1365
2014 Q4	$6K	Hold	101	–	–	﹤0.01%	600
2014 Q3	$5K	Buy	101 +1	+1%	+$51	﹤0.01%	640
2014 Q2	$5K	Hold	100	–	–	﹤0.01%	677
2014 Q1	$4K	Hold	100	–	–	﹤0.01%	702
2013 Q4	$5K	Hold	100	–	–	﹤0.01%	683
2013 Q3	$5K	Hold	100	–	–	﹤0.01%	595
2013 Q2	$4K	Buy	+100	New	+$4.75K	﹤0.01%	666

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

Reilly Financial Advisors's RMD Position: Q4 2021 in Review

Reilly Financial Advisors sold out of ResMed (RMD) in Q4 2021, closing a stake of 101 shares — an estimated $27K sold.

Reilly Financial Advisors first reported a position in RMD in Q2 2013 and held it in 12 quarters. The position peaked at $27K in Q3 2021. 724 funds tracked by Wall St. Rank hold RMD as of Q4 2021.

Reilly Financial Advisors reported no remaining ResMed position as of Q4 2021 after selling out during the quarter.
Reilly Financial Advisors sold 101 ResMed shares in Q4 2021, an estimated $27K.
Reilly Financial Advisors first reported a position in ResMed in Q2 2013 and held it in 12 quarters.
Reilly Financial Advisors's ResMed position peaked at $27K in Q3 2021.
724 funds tracked by Wall St. Rank held ResMed as of Q4 2021.

Based on Reilly Financial Advisors's 13F filing for Q4 2021, filed 25 Jan 2022.